Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV⁺ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study.

Published in:

Advances in Therapy, 2023, v. 40, n. 3, p. 1267, doi. 10.1007/s12325-022-02383-z

By:

• Chaganti, Sridhar;
• Barlev, Arie;
• Caillard, Sophie;
• Choquet, Sylvain;
• Cwynarski, Kate;
• Friedetzky, Anke;
• González-Barca, Eva;
• Sadetsky, Natalia;
• Schneeberger, Stefan;
• Thirumalai, Dhanalakshmi;
• Zinzani, Pier L.;
• Trappe, Ralf U.

Publication type:

Article